Trial Profile
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Clinical Proof of Concept Study of Zileuton IR in Patients With Moderate to Severe Facial Acne Vulgaris
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Feb 2017
Price :
$35
*
At a glance
- Drugs Zileuton (Primary)
- Indications Acne vulgaris
- Focus Proof of concept; Therapeutic Use
- Sponsors Critical Therapeutics
- 21 Oct 2013 New trial record